1. AB0211 Which Disease Activity Score 28 (DAS28) Based Flare Criteria Impact on Functional Disability in Patients with Ra in Das28 Remission State Using The IORRA Cohort. (15th July 2016) Authors: Shidara, K.; Tanaka, E.; Inoue, E.; Yamaguchi, R.; Shimizu, Y.; Hoshi, D.; Sugimoto, N.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0224 Difficulty in Maintaining Full Physical Function for 10 Years in Patients with Early Rheumatoid Arthritis in Daily Clinical Practice. Analysis of the Iorra Cohort. (10th June 2014) Authors: Nakajima, A.; Inoue, E.; Shimizu, Y.; Kobayashi, A.; Shidara, K.; Seto, Y.; Hoshi, D.; Sugimoto, N.; Tanaka, E.; Taniguchi, A.; Momohara, S.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0308 Optimal timing for tocilizumab administration to patients with rheumatoid arthritis in japan based on a cost-effectiveness analysis using the iorra cohort study. (23rd January 2014) Authors: Tanaka, E.; Inoue, E.; Hoshi, D.; Shidara, K.; Sato, E.; Inoue, Y.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0387 Incidence and Risk Factors for Tuberculosis in Japanese Patients with Rheumatoid Arthritis During a 12-Year Observational Period Using the Iorra Cohort. (9th June 2015) Authors: Yamaguchi, R.; Shidara, K.; Tanaka, E.; Inoue, E.I.; Shimizu, Y.; Kobayashi, A.; Sugimoto, N.; Hoshi, D.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1022 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database. (23rd January 2014) Authors: Tanaka, E.; Inoue, E.; Hoshi, D.; Kobayashi, A.; Sugimoto, N.; Shidara, K.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study. (23rd January 2014) Authors: Tanaka, Y.; Takeuchi, T.; Amano, K.; Sato, E.; Nawata, M.; Nagasawa, H.; Hoshi, D.; Saito, K.; Fukuyo, S.; Hanami, K.; Kameda, H.; Kurasawa, T.; Kaneko, Y.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0046 Methotrexate Dose Reduction During DAS28 Remission was a Significant Factor Associated with Early Deterioration in Patients with Rheumatoid Arthritis from the Iorra Cohort. (9th June 2015) Authors: Shidara, K.; Inoue, E.; Tanaka, E.; Yamaguchi, R.; Shimizu, Y.; Hoshi, D.; Sugimoto, N.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0068 Sustaining remission as defined by the new acr/eular criteria leads to better quality of life in patients with rheumatoid arthritis. (23rd January 2014) Authors: Shidara, K.; Nakajima, A.; Inoue, E.; Hoshi, D.; Tanaka, E.; Inoue, Y.; Kobayashi, A.; Seto, Y.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0074 Status of Disease Activity, Functional Impairment and Treatment in Patients with Rheumatoid Arthritis and Comorbidities. (9th June 2015) Authors: Tanaka, E.; Inoue, E.; Yamaguchi, R.; Shimizu, Y.; Sugimoto, N.; Hoshi, D.; Shidara, K.; Sato, E.; Seto, Y.; Nakajima, A.; Momohara, S.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0096 Influence of dose titration of concomitant steroid and methotrexate during biologic therapy on remission rates in patients with rheumatoid arthritis according to the new ACR/EULAR remission criteria in daily practice based on the iorra cohort. (23rd January 2014) Authors: Shimizu, Y.; Tanaka, E.; Inoue, E.; Shidara, K.; Hoshi, D.; Sugimoto, N.; Sato, E.; Seto, Y.; Momohara, S.; Nakajima, A.; Taniguchi, A.; Yamanaka, H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗